Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue

Am J Pathol. 2003 Sep;163(3):901-11. doi: 10.1016/S0002-9440(10)63450-5.

Abstract

The expression of oncofetal H19 RNA and its localization/cellular source was analyzed in synovial tissue (ST) and isolated synovial macrophages (Mphi) or synovial fibroblasts (SFBs) by reverse transcriptase-polymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemistry. RT-PCR showed significantly higher H19 expression in ST from patients with rheumatoid arthritis (RA) (P = 0.000) and osteoarthritis (OA) (P = 0.009) than in normal/joint trauma controls (N/JT), but comparable levels in reactive arthritis. In situ hybridization demonstrated strong signals in all RA-ST samples (n = 8), with > or =85% positive cells in the lining layer, diffuse infiltrates, and stroma regions. In lymphoid aggregates and endothelial cells only 20% were positive. RA-ST contained a significantly higher percentage of strongly positive lining cells than OA-ST and N/JT-ST. H19 RNA was expressed in both Mphi and SFBs, as confirmed by RT-PCR in isolated RA Mphi and SFBs (n = 3). In RA-SFBs, low constitutive H19 RNA expression in culture (10% fetal calf serum) was strongly increased on starvation (3.5-fold, 1% fetal calf serum), with or without the addition of interleukin-1beta (10 to 100 U/ml), tumor necrosis factor-alpha (1 to 25 ng/ml), or platelet-derived growth factor-BB (2.5 to 10 U/ml). In OA-SFBs, this starvation-induced increase was lower (twofold), reaching significant differences compared with RA-SFBs after stimulation with interleukin-1beta and platelet-derived growth factor-BB. In both RA- and OA-SFBs, the MAP-kinase ERK-1/2 pathway and the phosphatidylinositol-3 kinase pathway influenced H19 RNA expression, as shown by inhibitor studies. Significant overexpression of H19 RNA and its increased sensitivity to starvation/cytokine regulation in RA suggests a pathogenetic role of this oncofetal gene, possibly reflecting embryonal dedifferentiation of the adult ST and/or ongoing inflammatory/oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antigens, Neoplasm / metabolism*
  • Arthritis, Reactive / metabolism
  • Arthritis, Rheumatoid / metabolism*
  • Becaplermin
  • Case-Control Studies
  • Cells, Cultured
  • Culture Media / chemistry
  • Culture Media / pharmacology
  • Female
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • In Situ Hybridization / methods
  • Interleukin-1 / pharmacology
  • Joints / injuries
  • Macrophages / metabolism
  • Male
  • Middle Aged
  • Osteoarthritis / metabolism
  • Platelet-Derived Growth Factor / pharmacology
  • Proto-Oncogene Proteins c-sis
  • RNA, Long Noncoding
  • RNA, Untranslated / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Synovial Membrane / metabolism*
  • Synovial Membrane / pathology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Wounds and Injuries / metabolism

Substances

  • Antigens, Neoplasm
  • Culture Media
  • H19 long non-coding RNA
  • Interleukin-1
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • RNA, Long Noncoding
  • RNA, Untranslated
  • Tumor Necrosis Factor-alpha
  • oncofetal antigens
  • Becaplermin